Clinical trial
A Real-world Observational Study of Outcomes Among Canadian Women With Bothersome VMS Associated With Menopause Who Are Treated With Fezolinetant in a Real-life Setting According to Routine Healthcare Practice
NCT07602530 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-world Observational Study of Outcomes Among Canadian Women With Bothersome VMS Associated With Menopause Who Are Treated With Fezolinetant in a Real-life Setting According to Routine Healthcare Practice
- Lead sponsor
- Astellas Pharma Europe Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 23, 2025
- Completion date
- November 30, 2027
- Enrollment
- 238 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.